RadNet Inc. (NASDAQ:RDNT) EVP Norman R. Hames sold 7,500 shares of the firm’s stock in a transaction on Monday, December 11th. The shares were sold at an average price of $9.68, for a total value of $72,600.00. Following the sale, the executive vice president now directly owns 397,587 shares of the company’s stock, valued at $3,848,642.16. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
RadNet Inc. (NASDAQ:RDNT) opened at $9.70 on Tuesday. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $459.57, a price-to-earnings ratio of 32.17, a PEG ratio of 3.24 and a beta of 0.82. RadNet Inc. has a 12 month low of $5.25 and a 12 month high of $11.90.
RadNet (NASDAQ:RDNT) last posted its quarterly earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, hitting the consensus estimate of $0.12. The company had revenue of $227.60 million during the quarter, compared to the consensus estimate of $232.84 million. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The firm’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.11 EPS. research analysts forecast that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.
Several hedge funds have recently bought and sold shares of RDNT. Airain ltd bought a new position in RadNet in the 2nd quarter worth about $100,000. National Planning Corp boosted its stake in RadNet by 9.8% in the 2nd quarter. National Planning Corp now owns 16,796 shares of the medical research company’s stock worth $132,000 after purchasing an additional 1,500 shares during the period. Bank of America Corp DE boosted its stake in RadNet by 5.9% in the 1st quarter. Bank of America Corp DE now owns 26,580 shares of the medical research company’s stock worth $157,000 after purchasing an additional 1,477 shares during the period. Prudential Financial Inc. boosted its stake in RadNet by 15.2% in the 2nd quarter. Prudential Financial Inc. now owns 20,410 shares of the medical research company’s stock worth $158,000 after purchasing an additional 2,700 shares during the period. Finally, Parallax Volatility Advisers L.P. boosted its stake in RadNet by 122.0% in the 2nd quarter. Parallax Volatility Advisers L.P. now owns 21,122 shares of the medical research company’s stock worth $164,000 after purchasing an additional 117,148 shares during the period. Institutional investors own 53.24% of the company’s stock.
Several brokerages have recently issued reports on RDNT. Zacks Investment Research lowered RadNet from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. TheStreet lowered RadNet from a “b-” rating to a “c” rating in a research report on Friday, October 27th. BidaskClub raised RadNet from a “buy” rating to a “strong-buy” rating in a research report on Thursday, August 24th. Finally, Jefferies Group raised RadNet from a “hold” rating to a “buy” rating and raised their target price for the company from $7.00 to $12.00 in a research report on Tuesday, August 22nd.
WARNING: This report was published by Transcript Daily and is owned by of Transcript Daily. If you are reading this report on another domain, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this report can be read at https://transcriptdaily.com/2017/12/12/radnet-inc-rdnt-evp-norman-r-hames-sells-7500-shares.html.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.